Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
1.860
+0.140 (8.14%)
Nov 18, 2025, 4:00 PM EST - Market closed
Venus Concept Revenue
Venus Concept had revenue of $13.78M in the quarter ending September 30, 2025, a decrease of -8.20%. This brings the company's revenue in the last twelve months to $58.88M, down -12.39% year-over-year. In the year 2024, Venus Concept had annual revenue of $64.83M, down -15.09%.
Revenue (ttm)
$58.88M
Revenue Growth
-12.39%
P/S Ratio
0.04
Revenue / Employee
$201,630
Employees
292
Market Cap
3.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.83M | -11.52M | -15.09% |
| Dec 31, 2023 | 76.35M | -23.14M | -23.26% |
| Dec 31, 2022 | 99.50M | -6.13M | -5.80% |
| Dec 31, 2021 | 105.62M | 27.61M | 35.39% |
| Dec 31, 2020 | 78.01M | -32.39M | -29.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VERO News
- 5 days ago - Venus Concept Inc. (VERO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Venus Concept Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 6 weeks ago - Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025 - GlobeNewsWire
- 2 months ago - Cellulite Treatment Market Size to Reach USD 5.19 Billion by 2032, Driven by Rising Demand for Non-Invasive Aesthetic Solutions | S&S Insider - GlobeNewsWire
- 3 months ago - Venus Concept Inc. (VERO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Venus Concept Announces Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025 - GlobeNewsWire